Full metadata record

DC Field Value Language
dc.contributor.authorPark, Jung-eun-
dc.contributor.authorSong, Chiman-
dc.contributor.authorChoi, Keehyun-
dc.contributor.authorSim, Taebo-
dc.contributor.authorMoon, Bongjin-
dc.contributor.authorRoh, Eun Joo-
dc.date.accessioned2024-01-20T11:30:18Z-
dc.date.available2024-01-20T11:30:18Z-
dc.date.created2021-09-05-
dc.date.issued2013-10-15-
dc.identifier.issn0960-894X-
dc.identifier.urihttps://pubs.kist.re.kr/handle/201004/127545-
dc.description.abstractA series of 3,4-diarylpyrrolidin-2-one was designed, prepared and evaluated as triple reuptake inhibitors for antidepressant. Most compounds exhibited comparable in vitro efficacy as norepinephrine and dopamine transporter reuptake inhibitors. Especially, 2i showed better potency than GBR-12909 (IC50 = 14 - nM) which was used as reference compound for dopamine transporter. In addition, 2a and 2b showed inhibition (5.17 mu M-85.6 nM) for three transporters. (C) 2013 Elsevier Ltd. All rights reserved.-
dc.languageEnglish-
dc.publisherPergamon Press Ltd.-
dc.subjectPHARMACOLOGICAL EVALUATION-
dc.subjectMAJOR DEPRESSION-
dc.subjectPROFILE-
dc.subjectPOTENT-
dc.subjectAGENTS-
dc.titleSynthesis and biological evaluation of novel 3,4-diaryl lactam derivatives as triple reuptake inhibitors-
dc.typeArticle-
dc.identifier.doi10.1016/j.bmcl.2013.08.062-
dc.description.journalClass1-
dc.identifier.bibliographicCitationBioorganic & Medicinal Chemistry Letters, v.23, no.20, pp.5515 - 5518-
dc.citation.titleBioorganic & Medicinal Chemistry Letters-
dc.citation.volume23-
dc.citation.number20-
dc.citation.startPage5515-
dc.citation.endPage5518-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.identifier.wosid000324304000008-
dc.identifier.scopusid2-s2.0-84884282193-
dc.relation.journalWebOfScienceCategoryChemistry, Medicinal-
dc.relation.journalWebOfScienceCategoryChemistry, Organic-
dc.relation.journalResearchAreaPharmacology & Pharmacy-
dc.relation.journalResearchAreaChemistry-
dc.type.docTypeArticle-
dc.subject.keywordPlusPHARMACOLOGICAL EVALUATION-
dc.subject.keywordPlusMAJOR DEPRESSION-
dc.subject.keywordPlusPROFILE-
dc.subject.keywordPlusPOTENT-
dc.subject.keywordPlusAGENTS-
dc.subject.keywordAuthorTriple reuptake inhibitors-
dc.subject.keywordAuthorMonoamine-
dc.subject.keywordAuthorReuptake-
dc.subject.keywordAuthorDepression-
dc.subject.keywordAuthorAntidepressant-
dc.subject.keywordAuthorSerotonin-
dc.subject.keywordAuthorDopamine-
dc.subject.keywordAuthorNorepinephrine-
dc.subject.keywordAuthorLactam-
Appears in Collections:
KIST Article > 2013
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE